DelveInsight’s Ophthalmic Laser Devices Market Insights Report 2030 provides the current and forecast market analysis, individual leading Ophthalmic Laser Devices companies’ market shares, challenges, Ophthalmic Laser Devices Market Drivers, barriers, trends, and key market Ophthalmic Laser Devices companies in the market.
To read more about the latest highlights related to the Ophthalmic Laser Devices Market @ https://www.delveinsight.com/report-store/ophthalmic-laser-devices-market
Key Takeaways from the Ophthalmic Laser Devices Market Report
- In January 2024, IRIDEX Corporation announced its next-generation platform, the IRIDEX 532 and IRIDEX 577 lasers, in the United States for the treatment of retinal illnesses and glaucoma. Strategic significance: Expands IRIDEX’s laser portfolio with continuous-wave and proprietary MicroPulse treatment modes.
- In January 2024, MERIDIAN AG received U.S. FDA approval for its MR Q series, providing a high-quality healthcare solution addressing the needs of patients and physicians worldwide. Strategic significance: Strengthens MERIDIAN AG’s ophthalmic laser portfolio in the U.S. market.
- In April 2023, Johnson & Johnson Vision received U.S. FDA 510(k) approval for its ELITA Femtosecond Laser. Strategic significance: Expands Johnson & Johnson Vision’s femtosecond laser offerings for ophthalmic procedures.
- The Ophthalmic Laser Devices market was valued at USD 1.43 billion in 2023 and is projected to reach USD 1.94 billion by 2030, growing at a CAGR of 4.44% during the forecast period from 2024 to 2030. Growth is anchored in the rising prevalence of ophthalmic diseases such as glaucoma, diabetic retinopathy, and cataracts, alongside rising technological development activity.
- North America is expected to hold the largest share in the global Ophthalmic Laser Devices market.
- The principal drivers are the rise in eye diseases like glaucoma and cataracts, which necessitate laser treatments; advancements in technology and the introduction of new products improving treatment options and outcomes; and rising product launch and acquisition activity among key market players.
- The leading Ophthalmic Laser Devices Companies include Alcon Inc., IRIDEX Corporation, Alna-Medicalsystem AG & Co. KG, BAUSCH + LOMB INCORPORATED, Lumenis Be Ltd., Abbott, NIDEK CO., LTD, MERIDIAN AG, Johnson & Johnson Vision, LIGHTMED, ZEISS, Navilas Academy, Aeon Meditec, Quantel Medical, Lumibird Medical, and Ziemer Ophthalmic Systems AG, among others.
To know more about why North America is leading the market growth in the Ophthalmic Laser Devices Market, Get a snapshot @ https://www.delveinsight.com/report-store/ophthalmic-laser-devices-market
Ophthalmic Laser Devices Overview
Ophthalmic lasers allow precise treatment of a range of eye problems with little risk of infection; many laser procedures are relatively pain-free and can be performed on an outpatient basis. These devices are widely used in the management of glaucoma, diabetic retinopathy, cataracts, and other ophthalmic conditions, offering targeted treatment that reduces recovery time and complication risk compared to alternative therapies.
Ophthalmic Laser Devices Market Key Growth Drivers
- According to the World Glaucoma Association, approximately 7.6 million individuals globally were identified with glaucoma in 2020, a figure anticipated to rise to 111.8 million by 2040, with as much as 90% of cases remaining undiagnosed in developed countries.
- The World Glaucoma Association projects that by 2040, over 11 million people will experience bilateral blindness due to glaucoma, driving demand for procedures such as selective laser trabeculoplasty (SLT) to reduce eye pressure and control disease progression.
- According to the International Agency for the Prevention of Blindness (IAPB) (2024), approximately 20% of individuals diagnosed with diabetes exhibited symptoms of diabetic retinopathy in 2020, affecting an estimated 103 million adults worldwide, with over 47 million facing vision-threatening forms requiring immediate intervention.
- Ophthalmic lasers play a crucial role in managing diabetic retinopathy by targeting problematic blood vessels in the eye, with advancements in laser technology making treatments more precise, safe, and accessible.
- Rising product launch activities and acquisitions continue to expand the market, exemplified by MERIDIAN AG’s April 2020 acquisition of OPTHALL, a Slovenian ophthalmic laser manufacturer, aimed at strengthening R&D and manufacturing capabilities.
- Better awareness and screening programs are helping detect ophthalmic conditions earlier, driving demand for laser treatments to protect vision and prevent blindness through 2030.
Get a sneak peek at the Ophthalmic Laser Devices Market Dynamics @ https://www.delveinsight.com/report-store/ophthalmic-laser-devices-market
Ophthalmic Laser Devices Market Segment Analysis
The Ophthalmic Laser Devices Market by Product Type (Argon Blue-Green Laser, Nd:YAG Laser, Krypton Red Laser, and Others), Application (Glaucoma, Diabetic Retinopathy, Cataracts, and Others), End-User (Hospitals and Clinics, Ambulatory Surgical Centers, Ophthalmic Centers, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World).
By Product Type: The Argon Blue-Green Laser segment is expected to hold the largest share in 2023, attributed to its wide applications and advantages. The argon laser produces visible blue-green light at wavelengths of 488 nm and 514 nm, which is absorbed by hemoglobin, melanin, and other retinal pigments, allowing precise targeting during laser surgery with faster patient healing and lower infection risk. It is beneficial in treating diabetic retinopathy, glaucoma, cataracts, and other conditions.
By Geography: North America is expected to hold the largest share in the global market in 2023, driven by rising incidence of eye disorders like diabetic retinopathy and glaucoma, along with the presence of prominent industry players and ongoing product development initiatives. According to the CDC (2023), around 9.6 million people with diabetes in the United States, or 2.6%, have diabetic retinopathy, and 1.84 million have vision-threatening diabetic retinopathy.
Which MedTech key players in the Ophthalmic Laser Devices Market are set to emerge as the trendsetter, explore @ https://www.delveinsight.com/report-store/ophthalmic-laser-devices-market
Ophthalmic Laser Devices Market Competitive Landscape
The Ophthalmic Laser Devices market features established players including Alcon Inc., IRIDEX Corporation, BAUSCH + LOMB INCORPORATED, Lumenis Be Ltd., Abbott, NIDEK CO., LTD, MERIDIAN AG, Johnson & Johnson Vision, and ZEISS, alongside specialized providers such as LIGHTMED, Navilas Academy, Aeon Meditec, Quantel Medical, Lumibird Medical, and Ziemer Ophthalmic Systems AG. Companies are pursuing continued product approvals, launches, and strategic collaborations, such as IRIDEX Corporation’s March 2021 partnership with Topcon Corporation to expand its market presence in Asia-Pacific.
Ophthalmic Laser Devices Companies
Alcon Inc., IRIDEX Corporation, Alna-Medicalsystem AG & Co. KG, BAUSCH + LOMB INCORPORATED, Lumenis Be Ltd., Abbott, NIDEK CO., LTD, MERIDIAN AG, Johnson & Johnson Vision, LIGHTMED, ZEISS, Navilas Academy, Aeon Meditec, Quantel Medical, Lumibird Medical, Ziemer Ophthalmic Systems AG, and others.
Ophthalmic Laser Devices Market Restraints
Despite steady momentum, the Ophthalmic Laser Devices market faces material constraints. The high cost of ophthalmic lasers and the risk of developing infection after treatment of ophthalmic disorders may restrict the growth of the overall market during the forecast period.
Interested in knowing the Ophthalmic Laser Devices Market by 2030? Click to get a snapshot of the Ophthalmic Laser Devices Market Trends- https://www.delveinsight.com/report-store/ophthalmic-laser-devices-market
Scope of the Ophthalmic Laser Devices Market Report
- Coverage- Global
- Forecast Period- 2024-2030
- Ophthalmic Laser Devices Companies- Alcon Inc., IRIDEX Corporation, Alna-Medicalsystem AG & Co. KG, BAUSCH + LOMB INCORPORATED, Lumenis Be Ltd., Abbott, NIDEK CO., LTD, MERIDIAN AG, Johnson & Johnson Vision, LIGHTMED, ZEISS, Navilas Academy, Aeon Meditec, Quantel Medical, Lumibird Medical, Ziemer Ophthalmic Systems AG, and others.
- Ophthalmic Laser Devices Market Restraints and Regulatory Analysis
- Ophthalmic Laser Devices Porter Five Forces Analysis and Market Assessment
Explore more information of the Ophthalmic Laser Devices Market Insights @ https://www.delveinsight.com/report-store/ophthalmic-laser-devices-market
Table of Contents
- Ophthalmic Laser Devices Market Report Introduction
- Ophthalmic Laser Devices Market Executive Summary
- Ophthalmic Laser Devices Competitive Landscape
- Ophthalmic Laser Devices Regulatory Analysis
- Ophthalmic Laser Devices Market Key Factors Analysis
- Ophthalmic Laser Devices Market Porter’s Five Forces Analysis
- Ophthalmic Laser Devices Market Assessment
- Ophthalmic Laser Devices Market Company and Product Profiles
- KOL Views
- Project Approach
- About DelveInsight
- Disclaimer & Contact Us
About Us
DelveInsight is a leading healthcare-focused market research and consulting firm that provides clients with high-quality market intelligence and analysis to support informed business decisions. With a team of experienced industry experts and a deep understanding of the life sciences and healthcare sectors, we offer customized research solutions and insights to clients across the globe. Connect with us to get high-quality, accurate, and real-time intelligence to stay ahead of the growth curve.
Contact Us
Kanishk
